2016
DOI: 10.1111/apha.12704
|View full text |Cite
|
Sign up to set email alerts
|

Reversing dobutamine‐induced tachycardia using ivabradine increases stroke volume with neutral effect on cardiac energetics in left ventricular post‐ischaemia dysfunction

Abstract: A combined infusion of dobutamine and ivabradine had a neutral effect on post-ischaemia LV efficiency and increased left ventricular output without an increase in HR.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
13
0

Year Published

2016
2016
2020
2020

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(15 citation statements)
references
References 41 publications
2
13
0
Order By: Relevance
“…In one experimental swine model, Bakkehaug et al [25] presented an ischemia-reperfusion protocol in 12 pigs after intermittent ligation of the left coronary arteries. Dobutamine infusion in post-ischemic heart increased CO by increasing significantly HR from 102 to 131 bpm (p < 0.05).…”
Section: Effects Of Ivabradine On Hemodynamic Parameters Hemodynamicmentioning
confidence: 99%
“…In one experimental swine model, Bakkehaug et al [25] presented an ischemia-reperfusion protocol in 12 pigs after intermittent ligation of the left coronary arteries. Dobutamine infusion in post-ischemic heart increased CO by increasing significantly HR from 102 to 131 bpm (p < 0.05).…”
Section: Effects Of Ivabradine On Hemodynamic Parameters Hemodynamicmentioning
confidence: 99%
“…In conclusion, results presented in the paper of Bakkehaug et al . () are promising and have to be confirmed by a clinical study to assess the effect of this strategy in the aim to counteract deleterious effects of dobutamine in patients with CS all the more as we lack data and because of poor outcomes in this setting.…”
Section: Ongoing Trials As Regards Cardiogenic Shockmentioning
confidence: 97%
“…In the study published in this journal, Bakkehaug et al . () reported a basic model of CS (Bakkehaug et al . ).…”
Section: Ongoing Trials As Regards Cardiogenic Shockmentioning
confidence: 99%
See 1 more Smart Citation
“…In a pre‐diabetic animal model, fibroblast growth factor 21 therapy improved LV function and metabolic symptoms . Post‐ischaemic LV dysfunction could be improved by a combined therapeutic inotropic support (dobutamine) and selective heart rate reduction (ivabradine) …”
Section: Contractile Function and Heart Failurementioning
confidence: 99%